Loading...
XSTOACOU
Market cap14mUSD
Dec 23, Last price  
11.00SEK
1D
2.80%
1Q
-23.88%
IPO
-47.12%
Name

Acousort AB

Chart & Performance

D1W1MN
XSTO:ACOU chart
P/E
—
P/S
15.54
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
5.22%
Rev. gr., 5y
57.93%
Revenues
11m
+112.59%
832,5471,947,1171,575,3492,722,0002,482,0001,074,0001,856,0004,928,0003,007,0004,963,00010,551,000
Net income
-17m
L+29.35%
-62,720108,009-278,849-830,000-6,072,000-8,960,000-9,683,000-8,220,000-12,381,000-13,211,000-17,089,000
CFO
-32m
L
-3,012,000-8,597,000-757,000-214,000-8,525,000-7,397,000-9,843,000-7,035,000-10,918,0003,965,000-31,559,000

Profile

AcouSort AB (publ), a technology company, develops products and solutions for automated preparation of biological samples based on acoustofluidics technology for researchers and life science companies. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an integrated blood plasma separation module that enables in-line analysis of blood plasma from whole blood samples; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company was founded in 2010 and is based in Lund, Sweden.
URL
https://acousort.com/
IPO date
Jan 09, 2017
Employees
13
Domiciled in
SE
Incorporated in
SE

Valuation

Title
SEK in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
10,551
112.59%
4,963
65.05%
3,007
-38.98%
Cost of revenue
2,162
8,564
6,183
Unusual Expense (Income)
NOPBT
8,389
(3,601)
(3,176)
NOPBT Margin
79.51%
Operating Taxes
(569)
181
Tax Rate
NOPAT
8,389
(3,032)
(3,357)
Net income
(17,089)
29.35%
(13,211)
6.70%
(12,381)
50.62%
Dividends
Dividend yield
Proceeds from repurchase of equity
22,079
38,085
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
1,046
Net debt
(24,010)
(33,974)
(31,521)
Cash flow
Cash from operating activities
(31,559)
3,965
(10,918)
CAPEX
(213)
(1,011)
(1,314)
Cash from investing activities
(1,155)
(1,011)
(1,314)
Cash from financing activities
22,079
35,630
FCF
8,839
(2,523)
(3,320)
Balance
Cash
23,986
33,974
31,521
Long term investments
24
Excess cash
23,482
33,726
31,371
Stockholders' equity
(75,143)
(59,979)
(46,473)
Invested Capital
99,278
80,051
79,450
ROIC
9.36%
ROCE
34.76%
EV
Common stock shares outstanding
13,294
13,259
13,259
Price
Market cap
EV
EBITDA
9,172
(2,680)
(2,538)
EV/EBITDA
Interest
15
181
Interest/NOPBT